Business & Management

Business & Management Experts

Daniel Teper

Business Development
Immune Pharmaceuticals Inc.


Dr. Daniel Teper is the founder Immune Pharmaceuticals and Chief Executive Officer of the company’s immuno-oncology subsidiary, Cytovia. He served as Chief Executive Officer of Immune Pharmaceuticals from its founding until April 2017. . He was the Managing Director for North America at Bionest Partners, a global Strategy Consulting firm advising pharmaceutical and public biotechnology companies and previously a New York based Partner at ISO Healthcare Consulting (now part of Deloitte Monitor). Daniel started his career at Novartis Global Headquarters in Basel and then in the United States where he had growing responsibilities in sales, marketing and new product development. He held senior executive positions in Europe, first at GSK as Head of Commercial Operations for Glaxo France and then as President and President of Laboratoires Delagrange through the acquisition by Synthelabo (now part of Sanofi). He then became Global President HAVAS Health, a leading marketing and communication group, where he helped launch multiple industry blockbusters. Daniel was a cofounder of Novagali (NYSE Euronext: NOVA), which was acquired by Japan’s Santen. Daniel holds a Doctor of Pharmacy degree (PharmD) from Paris XI University and an MBA from INSEAD.

Research Interest

Business Development 

Global Experts from Israel

Global Experts in Subject

Share This Profile